Outcomes of everolimus-treated HR+/HER2− breast cancer

Peng‐Hui Wang, Szu‐Ting Yang, Tsung‐Cheng Kuo

2025Journal of the Chinese Medical Association19 citationsDOI Open Access PDF

Topics & Concepts

MedicineEverolimusOncologyBreast cancerInternal medicineCancerGynecologyPI3K/AKT/mTOR signaling in cancerAdvanced Breast Cancer Therapies